Abstract:One challenge in the heterologous expression of microsomal cytochrome P450 monooxygenases (P450s) is fulfilling their obligatory requirement for electrons transferred from NADPH P450 reductase. We have established co-expression parameters for Papilio polyxenes CYP6B1 and house fly P450 reductase in baculovirus-infected Sf9 cells that allow for efficient expression of both components and significantly enhance metabolic turnover of this insect P450's substrates. These expression conditions have allowed us to reexamine the turnover capacities of CYP6B1 toward linear and angular furanocoumarins present in the host plants for the specialist caterpillar P. polyxenes. Coexpression of CYP6B1 and P450 reductase at equivalent viral concentrations [MOI (multiplicity of infection) ratio of 1] results in turnover rates for the linear furanocoumarins xanthotoxin and psoralen, which are increased 32-33 fold over the turnover rates obtained with CYP6B1 expressed alone. The turnover rate for the angular furanocoumarin angelicin is also significantly increased to 4.76 nmol/min/nmol P450 compared to its barely detectable level obtained with CYP6B1 expressed alone. Substrate binding analyses indicate that all three of these compounds elicit typical type I binding spectra but with varying magnitudes and affinities that are indicative of each substrate's effectiveness at coordinating with the heme iron. The relative proportions of high spin state generated with these substrates are consistent with CYP6B1 metabolizing these furanocoumarins in the rank order xanthotoxin>psoralen>angelicin. These differential activities for CYP6B1 suggest that it may have been an ancient participant in the coevolutionary arms race between papilionid butterflies and their apiaceous host plants. Due to its ability to handle a range of furanocoumarin structures, CYP6B1 may have contributed to P. polyxenes' early colonization of linear furanocoumarin-containing plants and to its subsequent colonization of angular furanocoumarin-containing plants.

Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2

Precision Biotransformation of Emerging Pollutants by Human Cytochrome P450 Using Computational–Experimental Synergy: A Case Study of Tris(1,3-dichloro-2-propyl) Phosphate

Using Physical Organic Chemistry Knowledge to Predict Unusual Metabolites of Synthetic Phenolic Antioxidants by Cytochrome P450.

Deciphering the biotransformation mechanism of dialkylresorcinols by CYP4F11

Antibacterial and Anti-Biofilm Activity of Pyrones from a Pseudomonas Mosselii Strain.

A Bacterial Cytochrome P450 Enzyme Catalyzes Multistep Oxidation Reactions in Pyrroindomycin Biosynthesis

Biotechnological Synthesis of Drug Metabolites Using Human Cytochrome P450 2d6 Heterologously Expressed in Fission Yeast Exemplified for the Designer Drug Metabolite 4 '-Hydroxymethyl-alpha-pyrrolidinobutyrophenone

Identification of a Novel Cytochrome P450 Enzyme That Catalyzes the C-2α Hydroxylation of Pentacyclic Triterpenoids and Its Application in Yeast Cell Factories

Expected and Unexpected Products from the Biochemical Oxidation of Bacterial Alkylquinolones with CYP4F11.

Metabolism of Linear and Angular Furanocoumarins by Papilio Polyxenes Cyp6b1 Co-Expressed with Nadph Cytochrome P450 Reductase

Epoxidation of perillyl alcohol by engineered bacterial cytochrome P450 BM3

Biocatalytical asymmetric sulfoxidation by identifying cytochrome P450 from Parvibaculum lavamentivorans DS-1

Functional Characterization and Mechanistic Modeling of the Human Cytochrome P450 Enzyme CYP4A22

Human CYP4Z1 Catalyzes the In-Chain Hydroxylation of Lauric Acid and Myristic Acid

Mechanistic Studies on A P450-Mediated Rearrangement of Bms-690514: Conversion of A Pyrrolotriazine to A Hydroxypyridotriazine

Studies on the Chemical Diversities of Secondary Metabolites Produced by Neosartorya Fischeri Via the OSMAC Method.

Production of (hydroxy)benzoate-derived polyketides by engineered Pseudomonas with in situ extraction

Biotransformation of Modified Benzylisoquinoline Alkaloids: Boldine and Berberine and In Silico Molecular Docking Studies of Metabolites on Telomerase and Human Protein Tyrosine Phosphatase 1B

Molecular Docking Of Substrates And Inhibitors In The Catalytic Site Of Cyp6b1, An Insect Cytochrome P450 Monooxygenase

Efficient Substrate Screening and Inhibitor Testing of Human CYP4Z1 Using Permeabilized Recombinant Fission Yeast

Biotechnological synthesis of drug metabolites using P 450-expressing fission yeast – new perspectives in metabolism studies for 4 ’ methyl-a-pyrrolidinobutyrophenone